Anti-RN146/ RNF146 monoclonal antibody

Anti-RN146/ RNF146 antibody for FACS & in-vivo assay

Target products collectionGo to RNF146/RNF146 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2306-Ab-1/ GM-Tg-hg-MP2306-Ab-2Anti-Human RNF146 monoclonal antibodyHuman
GM-Tg-rg-MP2306-Ab-1/ GM-Tg-rg-MP2306-Ab-2Anti-Rat RNF146 monoclonal antibodyRat
GM-Tg-mg-MP2306-Ab-1/ GM-Tg-mg-MP2306-Ab-2Anti-Mouse RNF146 monoclonal antibodyMouse
GM-Tg-cynog-MP2306-Ab-1/ GM-Tg-cynog-MP2306-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF146 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2306-Ab-1/ GM-Tg-felg-MP2306-Ab-2Anti-Feline RNF146 monoclonal antibodyFeline
GM-Tg-cang-MP2306-Ab-1/ GM-Tg-cang-MP2306-Ab-2Anti-Canine RNF146 monoclonal antibodyCanine
GM-Tg-bovg-MP2306-Ab-1/ GM-Tg-bovg-MP2306-Ab-2Anti-Bovine RNF146 monoclonal antibodyBovine
GM-Tg-equg-MP2306-Ab-1/ GM-Tg-equg-MP2306-Ab-2Anti-Equine RNF146 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2306-Ab-1/ GM-Tg-hg-MP2306-Ab-2; GM-Tg-rg-MP2306-Ab-1/ GM-Tg-rg-MP2306-Ab-2;
GM-Tg-mg-MP2306-Ab-1/ GM-Tg-mg-MP2306-Ab-2; GM-Tg-cynog-MP2306-Ab-1/ GM-Tg-cynog-MP2306-Ab-2;
GM-Tg-felg-MP2306-Ab-1/ GM-Tg-felg-MP2306-Ab-2; GM-Tg-cang-MP2306-Ab-1/ GM-Tg-cang-MP2306-Ab-2;
GM-Tg-bovg-MP2306-Ab-1/ GM-Tg-bovg-MP2306-Ab-2; GM-Tg-equg-MP2306-Ab-1/ GM-Tg-equg-MP2306-Ab-2
Products NameAnti-RNF146 monoclonal antibody
Formatmab
Target NameRNF146
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RNF146 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RN146/ RNF146 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001998human RNF146 Lentivirus plasmid
    ORF Viral VectorvGMLP001998human RNF146 Lentivirus particle
    ORF Viral VectorpGMLPm002912mouse Rnf146 Lentivirus plasmid
    ORF Viral VectorvGMLPm002912mouse Rnf146 Lentivirus particle


    Target information

    Target IDGM-MP2306
    Target NameRNF146
    Gene ID81847,68031,308051,712152,476288,101085893,767901,100067400
    Gene Symbol and Synonyms2610509H23Rik,Iduna,RNF146,RNF146B
    Uniprot AccessionQ9NTX7,Q5XIK5,Q3T139
    Uniprot Entry NameRN146_HUMAN,RN146_RAT,R146B_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000118518
    Target ClassificationN/A

    The target: RNF146, gene name: RNF146, also named as . Enables poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Involved in positive regulation of canonical Wnt signaling pathway; protein ubiquitination; and ubiquitin-dependent protein catabolic process. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.